postpartum depression

FDA approves first drug for postpartum depression

On March 19, the FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression. Zulresso will be available only through a restricted program…

Paternal postpartum depression

Prevent and screen for depression in new fathers. Takeaways: Paternal postpartum depression effects one in ten fathers. Paternal postpartum depression can affect fathers, the likelihood of the mother…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.